Browsing: ARPAH

The US government’s health research moonshot agency has launched a five-year, $160 million bet that the era of bespoke gene-editing cures — currently limited to children whose families can access a vast scientific team willing to absorb the cost — can be converted into an industrial platform available to the 30 million Americans living with…